CN102988537B - 清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 - Google Patents
清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 Download PDFInfo
- Publication number
- CN102988537B CN102988537B CN201210550177.XA CN201210550177A CN102988537B CN 102988537 B CN102988537 B CN 102988537B CN 201210550177 A CN201210550177 A CN 201210550177A CN 102988537 B CN102988537 B CN 102988537B
- Authority
- CN
- China
- Prior art keywords
- fructus gardeniae
- medicine
- ndm
- filter
- drug resistant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 239000003814 drug Substances 0.000 title claims abstract description 59
- 241000894006 Bacteria Species 0.000 title abstract description 17
- 235000018958 Gardenia augusta Nutrition 0.000 title abstract description 4
- 239000008923 Qingkailing Substances 0.000 title abstract description 3
- 244000111489 Gardenia augusta Species 0.000 title abstract 3
- 229940079593 drug Drugs 0.000 claims abstract description 36
- 101000740455 Klebsiella pneumoniae Metallo-beta-lactamase type 2 Proteins 0.000 claims abstract description 28
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 19
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 34
- 239000000284 extract Substances 0.000 claims description 27
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 239000000706 filtrate Substances 0.000 claims description 12
- 238000002360 preparation method Methods 0.000 claims description 11
- 230000001580 bacterial effect Effects 0.000 claims description 9
- 238000004064 recycling Methods 0.000 claims description 6
- 238000004321 preservation Methods 0.000 claims description 5
- 239000003463 adsorbent Substances 0.000 claims description 3
- 238000013019 agitation Methods 0.000 claims description 3
- 230000006837 decompression Effects 0.000 claims description 3
- 239000003480 eluent Substances 0.000 claims description 3
- 238000010828 elution Methods 0.000 claims description 3
- 239000011347 resin Substances 0.000 claims description 3
- 229920005989 resin Polymers 0.000 claims description 3
- 239000007788 liquid Substances 0.000 claims description 2
- 241000588724 Escherichia coli Species 0.000 abstract description 15
- 241000588624 Acinetobacter calcoaceticus Species 0.000 abstract description 11
- 201000010099 disease Diseases 0.000 abstract description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 9
- 241000588626 Acinetobacter baumannii Species 0.000 abstract description 6
- 230000002401 inhibitory effect Effects 0.000 abstract description 6
- 241000122973 Stenotrophomonas maltophilia Species 0.000 abstract description 4
- 230000000694 effects Effects 0.000 abstract description 3
- 208000035143 Bacterial infection Diseases 0.000 abstract 1
- 241000589291 Acinetobacter Species 0.000 description 9
- 230000000844 anti-bacterial effect Effects 0.000 description 8
- 235000013305 food Nutrition 0.000 description 8
- 241000588902 Zymomonas mobilis Species 0.000 description 7
- 208000015181 infectious disease Diseases 0.000 description 6
- 230000003115 biocidal effect Effects 0.000 description 5
- 208000031729 Bacteremia Diseases 0.000 description 4
- 239000013612 plasmid Substances 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 229920001817 Agar Polymers 0.000 description 3
- 206010059866 Drug resistance Diseases 0.000 description 3
- 239000008272 agar Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 230000001717 pathogenic effect Effects 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical class O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 206010022678 Intestinal infections Diseases 0.000 description 2
- 201000009906 Meningitis Diseases 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010048038 Wound infection Diseases 0.000 description 2
- 229940126575 aminoglycoside Drugs 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 230000001408 fungistatic effect Effects 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 239000000825 pharmaceutical preparation Substances 0.000 description 2
- 230000003285 pharmacodynamic effect Effects 0.000 description 2
- 210000002345 respiratory system Anatomy 0.000 description 2
- 206010040872 skin infection Diseases 0.000 description 2
- 150000003952 β-lactams Chemical class 0.000 description 2
- 206010008631 Cholera Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- 241000588921 Enterobacteriaceae Species 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 240000004859 Gamochaeta purpurea Species 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 206010020772 Hypertension Diseases 0.000 description 1
- 101100111649 Klebsiella pneumoniae blaNDM-1 gene Proteins 0.000 description 1
- 239000006142 Luria-Bertani Agar Substances 0.000 description 1
- 241000607292 Maguireothamnus speciosus Species 0.000 description 1
- 241000607768 Shigella Species 0.000 description 1
- 206010041925 Staphylococcal infections Diseases 0.000 description 1
- 238000002814 agar dilution Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 108010034752 beta-lactamase NDM-1 Proteins 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- YZBQHRLRFGPBSL-RXMQYKEDSA-N carbapenem Chemical compound C1C=CN2C(=O)C[C@H]21 YZBQHRLRFGPBSL-RXMQYKEDSA-N 0.000 description 1
- 229940041011 carbapenems Drugs 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001143 conditioned effect Effects 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 229940124307 fluoroquinolone Drugs 0.000 description 1
- 210000000232 gallbladder Anatomy 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 239000001963 growth medium Substances 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 230000002443 hepatoprotective effect Effects 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 239000002609 medium Substances 0.000 description 1
- 208000015688 methicillin-resistant staphylococcus aureus infectious disease Diseases 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 239000000178 monomer Substances 0.000 description 1
- 201000009671 multidrug-resistant tuberculosis Diseases 0.000 description 1
- 108010074858 plaferon Proteins 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000002685 pulmonary effect Effects 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
Classifications
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Plant Substances (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Abstract
Description
Claims (1)
Priority Applications (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410503006.0A CN104474070B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗乙酸钙不动杆菌药物中的应用 |
CN201410502785.2A CN104398623B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗嗜麦芽寡养窄食单胞菌药物中的应用 |
CN201410502476.5A CN104383047B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗鲍曼不动杆菌药物中的应用 |
CN201210550177.XA CN102988537B (zh) | 2012-12-17 | 2012-12-17 | 清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201210550177.XA CN102988537B (zh) | 2012-12-17 | 2012-12-17 | 清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 |
Related Child Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410503006.0A Division CN104474070B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗乙酸钙不动杆菌药物中的应用 |
CN201410502785.2A Division CN104398623B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗嗜麦芽寡养窄食单胞菌药物中的应用 |
CN201410502576.8A Division CN104383048A (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗含ndm-1耐药基因大肠杆菌药物中的应用 |
CN201410502476.5A Division CN104383047B (zh) | 2012-12-17 | 2012-12-17 | 栀子提取物在制备抗鲍曼不动杆菌药物中的应用 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN102988537A CN102988537A (zh) | 2013-03-27 |
CN102988537B true CN102988537B (zh) | 2015-01-28 |
Family
ID=47917964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201210550177.XA Active CN102988537B (zh) | 2012-12-17 | 2012-12-17 | 清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN102988537B (zh) |
-
2012
- 2012-12-17 CN CN201210550177.XA patent/CN102988537B/zh active Active
Non-Patent Citations (2)
Title |
---|
大孔树脂提取栀子有效部位的工艺研究;汤燕等;《四川中医》;20081231;第26卷(第10期);57-58 * |
水产动物常见病原菌的耐药性分析及中草药体外抑菌活性的检测;张传亮等;《中国微生态学杂志》;20070430;第19卷(第02期);152-157 * |
Also Published As
Publication number | Publication date |
---|---|
CN102988537A (zh) | 2013-03-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN103665111B (zh) | 一种青环海蛇抗菌肽Hc-CATH的改造体HC-15及其制备方法和应用 | |
US7807622B2 (en) | Composition and use of phyto-percolate for treatment of disease | |
He et al. | Inhibitory effects of chitosan combined with nisin on Shewanella spp. isolated from Pseudosciaena crocea | |
Snyder et al. | Asaia bogorensis peritonitis identified by 16S ribosomal RNA sequence analysis in a patient receiving peritoneal dialysis | |
CN103814967A (zh) | 一种水产消毒用的中草药颗粒制剂及其制备方法 | |
Shahwany et al. | Antibacterial and anti-biofilm activity of three phenolic plant extracts and silver nanoparticles on Staphylococcus aureus and Klebsiella pneumoniae | |
EP1954800A2 (en) | Composition and use of phyto-percolate for treatment of disease | |
WO2010147145A1 (ja) | 抗グラム陰性菌剤 | |
CN104383047A (zh) | 栀子提取物在制备抗鲍曼不动杆菌药物中的应用 | |
CN104177485B (zh) | 一种扬子鳄抗菌肽Alligatorin6及其应用 | |
Fernandes et al. | The antimicrobial effect of wine on Listeria innocua in a model stomach system | |
CN115414391A (zh) | 植物乳杆菌ma2在制备预防或改善由腺嘌呤诱导的慢性肾脏疾病中的应用 | |
Jalalvandi et al. | The study of inhibitory effects of satureja khuzestanica essence against mexa and mexr efflux genes ofpseudomonas aeruginosa by rt-pcr | |
CN103006679B (zh) | 清开灵活性组分黄芩苷在制备抗多重耐药菌的药物中的应用 | |
Pan et al. | Polysaccharide ORP-1 isolated from Oudemansiella raphanipes ameliorates age-associated intestinal epithelial barrier dysfunction in Caco-2 cells monolayer | |
CN103040897B (zh) | 清开灵活性组分板蓝根提取物在制备抗多重耐药菌药物中的应用 | |
CN102988537B (zh) | 清开灵活性组分栀子提取物在制备抗多重耐药菌的药物中的应用 | |
KR101270088B1 (ko) | 바실러스 세레우스에 항균력을 갖는 식물유래 천연항균 조성물 | |
CN104398623A (zh) | 栀子提取物在制备抗嗜麦芽寡养窄食单胞菌药物中的应用 | |
CN104383048A (zh) | 栀子提取物在制备抗含ndm-1耐药基因大肠杆菌药物中的应用 | |
CN104474070A (zh) | 栀子提取物在制备抗乙酸钙不动杆菌药物中的应用 | |
CN102988456A (zh) | 清开灵活性组分金银花提取物在制备抗多重耐药菌的药物中的应用 | |
CN103798301B (zh) | 一种具有抗菌作用的中药复方总黄酮及其制备方法 | |
Wan et al. | Extraction of antibacterial peptides against Helicobacter pylori from bovine milk casein | |
Nawi et al. | The Inhibitory Effect of Lemon Juice (Citrus limon) on Vibrio parahaemolyticus in Raw Oyster (Crassostrea virginica) |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
ASS | Succession or assignment of patent right |
Owner name: SHINEWAY PHARMACEUTICAL GROUP LIMITED Free format text: FORMER OWNER: HEBEI SHINEWAY PHARMACEUTICAL CO., LTD. Effective date: 20150105 |
|
C41 | Transfer of patent application or patent right or utility model | ||
COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 065201 LANGFANG, HEBEI PROVINCE TO: 051430 SHIJIAZHUANG, HEBEI PROVINCE |
|
TA01 | Transfer of patent application right |
Effective date of registration: 20150105 Address after: South Luancheng County 051430 Hebei city of Shijiazhuang Province Applicant after: China Shineway Pharmaceutical Group Co., Ltd. Address before: 065201 Yingbin Road 682, Yanjiao Development Zone, Langfang, Hebei, Sanhe Applicant before: Hebei Shineway Pharmaceutical Co., Ltd. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant |